Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 22062805 | HLA-A*02 | stem cell transplantation | NA | NA | NA | unclassified | |
| we applied the hla-a2/hy dextramers on cryopreserved skin biopsy specimens from seven male hla-a2(+) pediatric patients who underwent stem cell transplantation with confirmed agvhd involving the skin. | |||||||
| 22084943 | HLA-CLASS I (HLA CLASS II) | stem cell transplantation | NA | NA | NA | unclassified | |
| eight consecutive patients undergoing allogeneic stem cell transplantation (tx) were transfused with apheresis plts of nonself human leukocyte antigen (hla) class i types, and hla class i discrepancy between donor and recipient was used to identify transfused plts. | |||||||
| 22084943 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| eight consecutive patients undergoing allogeneic stem cell transplantation (tx) were transfused with apheresis plts of nonself human leukocyte antigen (hla) class i types, and hla class i discrepancy between donor and recipient was used to identify transfused plts. | |||||||
| 22242318 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| cord blood stem cells are recognized as alternative donors for patients without hla matched sibling donors in allogeneic stem cell transplantation, while limited number of stem cells are still associated with delayed or failed engraftment. | |||||||
| 22665232 | HLA-E (HLA-E) | stem cell transplantation | NA | NA | NA | unclassified | |
| differences in expression levels between the different hla-e alleles have been reported and a role for hla-e polymorphism in stem cell transplantation has been postulated. | |||||||
| 23233586 | HLA MISMATCHED (HLA-MISMATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| the fundamental obstacle to the successful application of partially hla-mismatched related donor, or hla-haploidentical stem cell transplantation, is the strength of the host and donor t-cell response to allogeneic hla molecules, which results in increased incidences of graft failure, gvhd, and nonrelapse mortality. | |||||||
| 23463451 | HLA IDENTICAL (HLA-IDENTICAL) | stem cell transplantation | NA | NA | NA | unclassified | |
| antibody-mediated in vivo t cell depletion is common prior to unrelated (urd) or mismatched allogeneic stem cell transplantation (allosct) and optional in hla-identical sibling (fam) allosct. | |||||||
| 23601986 | HLA (HLA) | stem cell transplantation | NA | NA | NA | negative | |
| feasibility of an outpatient hla haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and cd3-cd19 depletion. | |||||||
| 23601986 | HLA MATCHED (HLA-MATCHED) | hematopoietic stem cell transplantation | NA | NA | NA | negation | |
| haploidentical hematopoietic stem cell transplantation (haplo-hsct) has been developed as an alternative transplant strategy for children with hematological disorders who do not have an hla-matched donor. | |||||||
| 23664940 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | fludarabine | NA | melphalan | NA | unclassified | |
| NA | |||||||
Copyright 2024